Gregg Nelson
@GreggNelsonERAS
Professor Gyn Oncology, Co-Chair Enhanced Recovery Canada, Physician Lead ERAS Alberta, Harvard MPH ‘26, #SocialMediaEditor @GynOncJnls
ID:880269442000617472
http://profiles.ucalgary.ca/gregory-nelson 29-06-2017 03:39:24
3,9K Tweets
1,6K Followers
667 Following
Follow People
YES!! Today was Full! 💜 FWC on the Move with Pure Barre to ⬆️ awareness & research💲for Uterine cancers…AND FWC Grant Recipient trial data just FDA approved for Uterine cancer!! Let’s all Empower More Research & More Tomorrows! Gregg Nelson 2024-move4her.raiselysite.com
This represents progress for our patients who will have more and better options to treat advanced or recurrent disease. Karen Lu Ginger J. Gardner Angeles Secord Debra Richardson, M.D. Eric Rios-Doria, MD Gregg Nelson erin medlin Matt Powell Jubilee Brown Anil Sood DrKatyMoore Amy Park, MD
📰🔥HOT OF THE PRESSES 🔥 📰Today the FDA granted approval ✅for durvalumab + carbo/taxol f/b durvalumab maintenance 💉in patients w/ dMMR, advanced/recurrent endometrial cancer. Congrats 🌟to SGO member Shannon Westin, MD, MPH, FASCO, The GOG Foundation Inc. & colleagues & AstraZeneca! #UCAM FdtnForWomensCancer
So honored to have Amanda Nickles Fader, MD at UChicago Ob/Gyn UChicagoCancerCenter as our Arthur L Herbst Gynecologic Oncology lecturer talking about career development and rare gyn cancers. Very inspiring! Nita Lee
Thank you to Amanda Nickles Fader, MD for being our invited Honoree for the Annual Arthur L. Herbst Lecture! #gyncsm UChicagoCancerCenter UChicago Ob/Gyn looking forward to seeing you and hearing your talk! #raretumors SGO FdtnForWomensCancer join in link below
Long-term follow-up of efficacy and safety of #selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
ASCO #ASCO24 The GOG Foundation Inc. Karyopharm sciencedirect.com/science/articl…
Great high risk #endometrialcancer session happening now with Angeles Secord Casey Cosgrove Ramez Eskander 🤩🤩 at #ASCO24
Learning so much 🤓